BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/11/2014 2:06:00 PM | Browse: 1230 | Download: 1615
 |
Received |
|
2014-01-02 09:15 |
 |
Peer-Review Started |
|
2014-01-02 15:18 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2014-03-20 20:18 |
 |
Revised |
|
2014-04-01 01:59 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2014-10-10 18:01 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2014-10-10 18:14 |
 |
Articles in Press |
|
2014-10-10 18:14 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-11-19 11:03 |
 |
Publish the Manuscript Online |
|
2014-12-11 14:23 |
| Category |
Oncology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Association of survivin splice variants with prognosis and treatment of breast cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Anastasia Pavlidou, Christos Kroupis and Kleanthi Dimas |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Christos Kroupis, MSc, PhD, Assistant Professor, Department of Clinical Biochemistry, Attikon University General Hospital, Rimini 1, Haidari 12462, Greece. ckroupis@med.uoa.gr |
| Key Words |
Survivin gene; Isoforms; Therapy; Prognosis; Breast cancer |
| Core Tip |
Besides wild type survivin full length transcript, another six splice variants have been identified. Overexpression of survivin and its isoforms leads to shorter overall and disease-free survival; the transcript variants are positively correlated with apoptosis and could assist prognosis prediction. It has been proved through numerous studies that inhibiting survivin isoforms might become a promising target of drug therapy of carcinomas. Use of small molecule YM155 could offer new therapy for triple negative breast cancer patients while, chemotherapy with FEC and Tax-Epi could be guided by survivin splice variants measurements. Survivin transcript variants could become prognostic biomarkers and could provide information about clinical management of patients suffering from breast cancer. |
| Publish Date |
2014-12-11 14:23 |
| Citation |
Pavlidou A, Kroupis C, Dimas K. Association of survivin splice variants with prognosis and treatment of breast cancer. World J Clin Oncol 2014; 5(5): 883-894 |
| URL |
http://www.wjgnet.com/2218-4333/full/v5/i5/883.htm |
| DOI |
http://dx.doi.org/10.5306/wjco.v5.i5.883 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.